Kiniksa Pharmaceuticals International, Plc KNSA Stock Forecast
AI-powered price prediction and analysis for Kiniksa Pharmaceuticals International, Plc ยท Updated Sep 25, 2026
See KNSA's Exact Price Target
Create a free account and follow this stock to unlock its full AI forecast โ 3 stocks free.
Sign Up Free with GooglePrice Chart
Key Statistics
About Kiniksa Pharmaceuticals International, Plc
Kiniksa Pharmaceuticals International, Plc (KNSA) operates in the Life Sciences sector, specifically in the Pharmaceutical Preparations industry. .
Latest News
Where KNSA sits on the market map
Pharmaceutical Preparations Peers
Companies sharing the same SEC industry code, one row per issuer, largest first - a classification match, not a curated list of competitors.
| Company | Ticker | AI Signal | Market Cap | P/E |
|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, โฆ | KNSA | โโ% | $11.76B | -x |
| Eli Lilly & โฆ | LLY | โโ% | $1.11T | 41.7x |
| Johnson & Johnson | JNJ | โโ% | $652.31B | 31.0x |
| Beone Medicines Ltd. | ONC | โโ% | $532.08B | -x |
| Abbvie Inc. | ABBV | โโ% | $468.43B | 74.2x |
| Merck & Co., โฆ | MRK | โโ% | $365.34B | 115.1x |
| Novartis Ag | NVS | โโ% | $272.31B | -x |
| Gsk Plc | GSK | โโ% | $214.26B | -x |
| Abbott Laboratories | ABT | โโ% | $180.26B | 28.6x |
| Pfizer Inc | PFE | โโ% | $160.62B | 37.1x |
| Vertex Pharmaceuticals Inc โฆ | VRTX | โโ% | $130.87B | 29.7x |
| Bristol Myers Squibb โฆ | BMY | โโ% | $125.63B | 13.5x |
| Regeneron Pharmaceuticals, Inc. | REGN | โโ% | $82.55B | 19.1x |
| Sanofi | SNY | โโ% | $50.80B | -x |
| Teva Pharmaceutical Industries โฆ | TEVA | โโ% | $45.46B | 64.3x |
| Alnylam Pharmaceuticals, Inc. | ALNY | โโ% | $33.40B | -x |
| Royalty Pharma Plc | RPRX | โโ% | $33.15B | 40.7x |
| Alterity Therapeutics Ltd | ATHE | โโ% | $32.40B | -x |
| Takeda Pharmaceutical Co โฆ | TAK | โโ% | $29.93B | -x |
| Zai Lab Ltd | ZLAB | โโ% | $29.68B | -x |
| Zoetis Inc. | ZTS | โโ% | $29.59B | 11.3x |
| Roivant Sciences Ltd. | ROIV | โโ% | $26.60B | -x |
| Insmed Inc | INSM | โโ% | $26.54B | -x |
| United Therapeutics Corp | UTHR | โโ% | $20.99B | 16.0x |
| Viatris Inc | VTRS | โโ% | $19.66B | -x |
| Jazz Pharmaceuticals Plc | JAZZ | โโ% | $15.34B | 16.3x |
| Ascendis Pharma A/S | ASND | โโ% | $14.30B | -x |
| Summit Therapeutics Inc. | SMMT | โโ% | $13.12B | -x |
| Bridgebio Pharma, Inc. | BBIO | โโ% | $12.96B | -x |
| Corcept Therapeutics Inc | CORT | โโ% | $12.81B | -x |
| Hutchmed (China) Ltd | HCM | โโ% | $12.13B | -x |
| Biomarin Pharmaceutical Inc | BMRN | โโ% | $11.88B | -x |
| Madrigal Pharmaceuticals, Inc. | MDGL | โโ% | $11.86B | -x |
| Elanco Animal Health โฆ | ELAN | โโ% | $11.17B | -x |
| Dr Reddys Laboratories โฆ | RDY | โโ% | $10.34B | -x |
| Axsome Therapeutics, Inc. | AXSM | โโ% | $10.27B | -x |
| Arrowhead Pharmaceuticals, Inc. | ARWR | โโ% | $9.33B | -x |
| Cytokinetics Inc | CYTK | โโ% | $9.13B | -x |
| Protagonist Therapeutics, Inc | PTGX | โโ% | $8.98B | -x |
| Praxis Precision Medicines, โฆ | PRAX | โโ% | $7.88B | -x |
| Spyre Therapeutics, Inc. | SYRE | โโ% | $7.77B | -x |
| Structure Therapeutics Inc. | GPCR | โโ% | $7.71B | -x |
| Abivax S.A. | ABVX | โโ% | $7.39B | -x |
| Ionis Pharmaceuticals Inc | IONS | โโ% | $7.28B | -x |
| Legend Biotech Corp | LEGN | โโ% | $7.05B | -x |
| Alkermes Plc. | ALKS | โโ% | $6.84B | -x |
| Rhythm Pharmaceuticals, Inc. | RYTM | โโ% | $6.76B | -x |
| Biolinerx Ltd. | BLRX | โโ% | $6.68B | -x |
| Belite Bio, Inc | BLTE | โโ% | $6.67B | -x |
| Liquidia Corp | LQDA | โโ% | $6.35B | -x |
| Amneal Pharmaceuticals, Inc. | AMRX | โโ% | $6.32B | -x |
| Ligand Pharmaceuticals Inc | LGND | โโ% | $5.96B | 30.2x |
| Mirum Pharmaceuticals, Inc. | MIRM | โโ% | $5.80B | -x |
| Amarin Corp Plc\Uk | AMRN | โโ% | $5.64B | -x |
| Travere Therapeutics, Inc. | TVTX | โโ% | $5.64B | -x |
| Cogent Biosciences, Inc. | COGT | โโ% | $5.45B | -x |
| Ptc Therapeutics, Inc. | PTCT | โโ% | $5.20B | -x |
| Erasca, Inc. | ERAS | โโ% | $5.08B | -x |
| Dianthus Therapeutics, Inc. โฆ | DNTH | โโ% | $5.07B | -x |
| Viking Therapeutics, Inc. | VKTX | โโ% | $4.86B | -x |
FAQ
-
Is Kiniksa Pharmaceuticals International, Plc a good stock to buy?
Our AI analyzes Kiniksa Pharmaceuticals International, Plc daily. Check the signal above for the latest recommendation. Always do your own research before investing.
-
How accurate are Kiniksa Pharmaceuticals International, Plc predictions?
A per-ticker accuracy statistic for KNSA is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
-
How often are forecasts updated?
Kiniksa Pharmaceuticals International, Plc forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on September 25, 2026.
Ready to invest smarter?
Join thousands of investors using AI-powered stock predictions
Sign Up FreeLooking for a deeper analysis of Kiniksa Pharmaceuticals International, Plc?
View full institutional-grade analysis on Intratio โAI predictions are based on historical patterns and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always do your own research.